Summary
Elevance Health, Inc. (formerly Anthem, Inc.) filed an 8-K on January 31, 2018, to report its fourth quarter and full-year financial results for 2017. While the specific financial figures are detailed in an attached press release (Exhibit 99.1), this filing serves to officially disseminate that information. Investors should note that the press release itself contains a comprehensive overview of the company's performance, including revenue, earnings, and any guidance provided for the upcoming period. Additionally, the 8-K announced a significant corporate governance update: the election of Bahija Jallal as an independent director to the Board, effective February 1, 2018. Ms. Jallal was also appointed to the Compensation and Governance Committees, indicating her immediate involvement in key board functions. This appointment is an important signal to investors regarding the composition and expertise of the company's leadership and its commitment to effective governance.
Key Highlights
- 1Filing disseminates financial results for the fourth quarter and full year ended December 31, 2017, via an attached press release.
- 2Bahija Jallal elected as an independent director to the Board of Directors, effective February 1, 2018.
- 3Ms. Jallal's term as director will expire at the 2019 annual meeting of shareholders.
- 4Ms. Jallal appointed to serve on the Compensation and Governance Committees of the Board.
- 5Information furnished in this 8-K is not deemed 'filed' for Section 18 purposes and generally not incorporated by reference into other SEC filings unless expressly stated.
- 6The company's name was Anthem, Inc. at the time of this filing.